Reset filter

PS14(PM) Statement on responsibility for co-prescription of oral and intrathecal opioids 2023

PS14(PM) Statement on the responsibility of specialist pain medicine physicians for overall opioid management in patients with chronic non-cancer pain who have an intrathecal opioid delivery device in situ 2023

FPM training agreement

2024 Faculty of Pain Medicine annual training agreement.

2024 FPM Spring Meeting HCI Prospectus

2024 FPM Spring Meeting healthcare industry prospectus

Redcliffe 1 20200619

ANZCA statement on PPE

ANZCA statement on personal protection equipment (PPE) during the SARS-CoV-2 pandemic

Reg 2 - Committees of ANZCA Council

Regulation 2 - Committees of ANZCA Council

11-Final-ANZCA-response-to-CAA-20180523-(002)

PS12(PM) Position statement on the use of ketamine in the management of chronic non-cancer pain

IMS 2023 HCI prospectus

Healthcare industry prospectus for the 2023 International Medical Symposium.

ANZCA Gender Pay Gap Employer Statement

Under the Workplace Gender Equality Amendment (Closing the Gender Pay Gap) 2023 and associated legislative instruments, organisations with more than 100 employees arerequired to have their gender pay gap published by the Workplace Gender Equality Agency (WGEA) along with an In...

First  < Prev   ... 11 12 13 14 15 16 17 18 19 20 ...   Next >  Last Pages: 20 of 48